epi procolon the blood test for colorectal cancer screening

Epi proColon: The Blood Test for Colorectal Cancer Screening

Epi proColon is the first and only FDA approved blood test for colon cancer screening. Benefits of Epi proColon include: 鈥?No pretest preparation 鈥?No stool handling 鈥?No dietary or medication restrictions 鈥?Available through national laboratories

  • Patients

    What is Epi proColon 庐?. Epi proColon 庐 is a blood test for...

    Intended Use

    路 Coding and Reimbursement

    路 Risk Factors for Colorectal Cancer

    路 Detection and Technology

    路 Patient Testing

    路 Questions & Answers

  • Medical Professionals

    What is Epi proColon 庐? Epi proColon is an FDA-approved...

  • Laboratories

    The Epi proColon 庐 Blood Test. Real-Time PCR 鈥?Single-Day...

    Complete Test Kit

    路 Clinical Trials Overview

  • E-Support Library

    Document Number: Document Title: Download: IFU 0008: Epi...

    Epi proColon Materials

    路 Epi proColon Publications

  • Contact

    Epigenomics Customer Support Email: [email protected]...

    • Colorectal Cancer Screening

      Methylated SEPT9 tumor DNA is a target of the Epi proColon...

    • Getting tested with Epi proColon

      Is Epi proColon Right for You? You should talk with your...

    • Test Accuracy

      Epi proColon Sensitivity = 68.2%: Epi proColon...

    • Benefits and Risks of Screening with Epi proColon

      These tests include colonoscopy, sigmoidoscopy and...

    • Understanding Your Test Results

      A positive blood test means that altered Septin 9 DNA has...

    • www.aafp.org 鈥?pubs 鈥?afpmSEPT9 Blood Test (Epi proColon) for Colorectal Cancer Screening

      www.aafp.org 鈥?pubs 鈥?afp

Epi proColon is an FDA-approved blood test for colorectal

Epi proColon庐. is an FDA-approved blood test for colorectal cancer screening. This test is intended for persons age 50 and older who are unwilling or unable to be screened by recommended methods. Rx Only.

Inquiry Now

Blood-based Biomarker Tests for Colorectal Cancer Screening

Epi proColon 庐 offers a convenient way of detecting colorectal cancer: in blood. It鈥檚 as simple as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells.

Inquiry Now

EPI proColon庐 鈥?Novel Blood Test Approved for Colorectal

Epi proColon 庐 2.0 CE is a blood-based test designed to aid in the early detection of colorectal cancer. The test comprises a qualitative assay for the polymerase chain reaction (PCR) detection of methylated Septin9 DNA, the presence of which is associated with colorectal cancer: however, 鈥?/span>

  • pubmed.ncbi.nlm.nih.gov 鈥?28811705Colorectal cancer screening: An updated review of the

    pubmed.ncbi.nlm.nih.gov 鈥?28811705

    Jul 28, 2017 路 Recently, FDA approved a blood-based test (Epi procolon 庐) for CRC screening. This blood based test may serve to increase the participation and adherence rates. Hence, leading to increase in colon cancer detection and prevention. This article will discuss various CRC screening tests with a particular focus on the data regarding the new

    Inquiry Now
  • mSEPT9 (Epi proColon) Blood Test for Colorectal Cancer Screening

    Epi proColon is the first and only blood test that provides an additional option for colorectal cancer screening for your patients who have received counseling and have a history of not completing screening by colonoscopy and fecal tests.

    Inquiry Now

    Epi proColon庐 - epigenomics

    Epi proColon 庐 offers a convenient way of detecting colorectal cancer: in blood. It鈥檚 as simple as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells.

    Inquiry Now

    EPI proColon庐 鈥?Novel Blood Test Approved for Colorectal

    Epi proColon is the first and only blood test that provides an additional option for colorectal cancer screening for your patients who have received counseling and have a history of not completing screening by colonoscopy and fecal tests. For more information, please visit the USPSTF colon cancer screening recommendation statement, available here.

    Inquiry Now

    Blood-Based Screening for Colon Cancer - JAMA Network

    On April 13, 2016, the US Food and Drug Administration (FDA) approved the first blood-based screening test for colon cancer. The assay (Epi proColon) relies on qualitative detection of the methylated septin 9 gene () and has been considered an innovation in screening.

    Inquiry Now

    Colon Cancer Workup: Approach Considerations, Blood Studies

    The National Comprehensive Cancer Network recommends that all patients younger than 70 years of age who are diagnosed with colorectal cancer be tested for hereditary nonpolyposis colon...

    Inquiry Now

    Questions & Answers - Epi proColon

    Epi proColon 庐 is a molecular, colorectal cancer screening test that detects methylated Septin 9 DNA in blood. DNA methylation of the SEPT9 gene is increased in colorectal cancer. Methylated SEPT9 DNA from tumors is shed into the bloodstream and the methylation pattern is detectable in plasma by Real-Time PCR. Why a blood test?

    Inquiry Now

    LabCorp Announces the Launch of the Epi proColon庐 Test for

    encourage screening participation [7,8]. The Epi proColon庐 test is the first and only blood test to gain FDA approval (April, 2016) for colorectal cancer screening. Background SEPT9 Gene hypermethylation As a normal process, DNA methylation is one of the most commonly occurring epigenetic events and vital components

    Inquiry Now